TRAM Snapshot of App at Pub for Oppostn

RLF-100

Relief Therapeutics Holding AG

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 90141290 FILING DATE 08/27/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY CROSS, TRACY L
L.O. ASSIGNED 109

PUB INFORMATION

RUN DATE 11/30/2021
PUB DATE N/A
STATUS 681-PUBLICATION/ISSUE REVIEW COMPLETE
STATUS DATE 11/30/2021
LITERAL MARK ELEMENT RLF-100

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) YES 1 (a) YES 1 (a) NO
1 (b) NO 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT RLF-100
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Relief Therapeutics Holding AG
ADDRESS 390 Park Avenue
New York, NY 10022
ENTITY 03-CORPORATION
CITIZENSHIP Switzerland

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 08/26/2020 FIRST USE IN COMMERCE DATE 08/26/2020 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
11/29/2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER 015
11/08/2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 014
11/08/2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 013
11/08/2021 ALIE A ASSIGNED TO LIE 012
11/02/2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 011
09/02/2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED 010
09/02/2021 GNSL S LETTER OF SUSPENSION E-MAILED 009
09/02/2021 CNSL R SUSPENSION LETTER WRITTEN 008
08/30/2021 RCCK S SUSPENSION CHECKED ? TO ATTORNEY FOR ACTION 007
12/29/2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED 006
12/29/2020 GNSL F LETTER OF SUSPENSION E-MAILED 005
12/29/2020 CNSL R SUSPENSION LETTER WRITTEN 004
12/28/2020 DOCK D ASSIGNED TO EXAMINER 003
09/30/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
08/31/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Heather M. Schneider
CORRESPONDENCE ADDRESS Heather M. Schneider
WILLKIE FARR & GALLAGHER LLP
787 SEVENTH AVENUE
NEW YORK NY 10019
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed